Emerging as a potential avenue for managing the debilitating effects of Multiple Disease, regenerative treatment is steadily gaining traction within the neurological field. While not a resolution, this groundbreaking approach aims to repair damaged myelin sheaths and lessen neurological impairment. Several clinical trials are currently in progress,